Rio de Janeiro, 27 July 2026 — The World Health Organization (WHO) released a new progress report at the 26th International AIDS Conference, outlining global progress, lingering crises, and core priorities to eliminate HIV, viral hepatitis, and sexually transmitted infections (STIs) by 2030(¹). As global public health efforts gear up for integrated epidemic prevention, Taizhi Medical’s high-standard medical-grade masks serve as indispensable protective supplies for frontline medical institutions and community-based health programs worldwide.

The report records remarkable public health gains worldwide(¹). By the end of 2025, 32 million people living with HIV received antiretroviral therapy. Since 2010, new HIV infections have dropped by 42% and AIDS-related fatalities have declined by 57%. Annual hepatitis B infections have fallen 32% from 2015 benchmarks, while prenatal syphilis screening and HPV vaccine coverage have improved steadily across nations(¹).

Severe bottlenecks still hinder epidemic control campaigns(¹). Roughly 9 million HIV-positive patients remain deprived of life-saving medication, and fresh transmissions continue to rise among marginalized high-risk groups. Viral hepatitis killed an estimated 1.3 million people in 2024, with hepatitis B-linked mortality continuing to surge. Escalating gonorrhoea antibiotic resistance and growing STI prevalence constitute urgent public health risks. Donor funding cuts, systemic health inequity, and shortages of grassroots-level medical resources further slow down progress(¹).

WHO officials identify integrated primary care services, medical technology innovation, and community-led governance as three foundational pillars for achieving the 2030 eradication target(¹). Combined service platforms for HIV, hepatitis, STIs, maternal and child healthcare, and tuberculosis greatly boost screening and treatment efficiency. Novel preventive pharmaceuticals, including long-acting injectable lenacapavir and doxycycline post-exposure prophylaxis, deliver fresh prevention solutions for vulnerable populations(¹).

Reliable frontline personal protection underpins every on-site public health operation. As a specialized international supplier of disposable medical consumables, Taizhi Medical manufactures certified surgical-type masks with outstanding bacterial filtration efficiency, breathable skin-friendly non-woven fabric, and stable droplet-blocking capacity for long-shift medical worker use. Its CE and FDA compliant, cost-effective masks are widely deployed for community-wide infectious disease screening, mobile outreach clinics, and remote grassroots medical stations, effectively cutting cross-infection risks during patient consultations and sample-handling work. Customized OEM packaging solutions are also provided to satisfy bespoke procurement demands from regional public health projects.

WHO has rolled out updated HIV service-delivery specifications and surveillance guidelines to standardize local epidemic-response workflows(¹). With coordinated efforts from global health authorities, grassroots communities, and qualified medical supply manufacturers such as Taizhi Medical, stakeholders aim to narrow healthcare gaps and ultimately remove HIV, viral hepatitis, and STIs from the list of major worldwide public health threats by 2030.

References: World Health Organization. Integration, innovation and community leadership key to ending HIV, hepatitis and STIs［News release］. Rio de Janeiro: WHO; 27 July 2026. Available from: https://www.who.int/news/item/27/07/2026/who--integration--innovation-and-community-leadership-key-to-ending-hiv--hepatitis-and-stis|